Skip to main content
SpringerLink
Log in

Basal Cell Carcinoma

  • Chapter
  • First Online:
Radiation Therapy for Sarcomas and Skin Cancers

Part of the book series: Practical Guides in Radiation Oncology ((PGRO))

  • 391 Accesses

Abstract

Basal cell carcinomas (BCC) represent the majority of non-melanoma skin cancers and has increased in incidence. Most lesions arise on the sun-exposed head and neck and trunk. While it is considered an indolent process, BCC can be locally invasive. There are unique subtypes with distinctive clinical and histologic features. The majority of BCC lesions present early and treatment is based rather on risk factors for recurrence. Management options include surgical excision and radiation therapy. Superficial external beam radiation or surface brachytherapy may be employed. A variety of techniques are utilized to maximize dose delivery to a lesion while minimizing dose to normal tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol. 2017;177(2):359–72. https://doi.org/10.1111/bjd.15321. Epub 2017 Feb 20.

    Article  Google Scholar 

  2. American Cancer Society. Cancer Facts & Figures 2019. Atlanta: American Cancer Society; 2019.

    Google Scholar 

  3. Rogers HW, et al. Incidence estimate of nonmelanoma skin Cancer in the United States. Arch Dermatol. 2010;146(3):283–7.

    Article  Google Scholar 

  4. Chen et al. The economics of skin Cancer: an analysis of medicare payment data. PRS Global Open 2016 1–7.

    Google Scholar 

  5. Geist DE, Garcia-Molner M, Fitzek MM, et al. Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management. Dermatol Surg. 2008;34:1642–51.

    Google Scholar 

  6. Rubin AI, Chen EH, Ratner D. Basal cell carcinoma. N Engl J Med. 2005;353:2262–9.

    Article  Google Scholar 

  7. Marcil I, Stern R. Risk of developing a subsequent non-melanoma skin cancer. J Am Acad Dermatol. 1990;23:1114–8.

    Article  Google Scholar 

  8. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147(1):41.

    Article  Google Scholar 

  9. Szewczyk M, Pazdrowski J, Danczak-Pazdrowska A, Golusinski P, Majchrzak E, Luczewski L, Marszałek S, Silny W, Golusinski W. Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma. Postȩpy dermatologii i alergologii. 2014;31:146–51. https://doi.org/10.5114/pdia.2014.40959.

    Article  Google Scholar 

  10. Califano JA, Lydiatt WM, Nehal KS, et al. Cutaneous squamous cell carcinoma of the head and neck. In: Amin MB, editor. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017. p. 171.

    Chapter  Google Scholar 

  11. National Comprehensive Cancer Network. Basal Cell Skin Cancer Version 1.2019. https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf. Accessed 7 Aug 2019.

  12. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315–28.

    Article  Google Scholar 

  13. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol. 1987;123(3):340–4.

    Article  Google Scholar 

  14. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15(4):424–31.

    Article  Google Scholar 

  15. Roozeboom MH, Arits AH, Nelemans PJ, Kelleners-Smeets NW. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol. 2012;167(4):733–56. https://doi.org/10.1111/j.1365-2133.2012.11061.x. Epub 2012 Sep 7.

    Article  Google Scholar 

  16. Wilder RB, Kittelson JM, Shimm DS. Basal cell carcinoma treated with radiation therapy. Cancer. 1991;68(10):2134–7.

    Article  Google Scholar 

  17. Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J. Interventions of non-metastatic squamous cell carcinoma of the skin: systemic review and pooled analysis of observational studies. BMJ. 2013;347:f6153. https://doi.org/10.1136/bmj.f6153.

    Article  Google Scholar 

  18. Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, Guillaume JC, Chalon R, Petit JY, Sancho-Garnier H, Prade M, Bouzy J, Chassagne D. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997;76(1):100–6.

    Article  Google Scholar 

  19. Patel R, et al. Comparison of electronic brachytherapy and MMS for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study. J Contemp Brachytherapy. 2017;4:338–44.

    Article  Google Scholar 

  20. Moss WT, Stevens KR, Garcia R. Skin cancer in treatment planning. In: Khan FM, Potish RA, editors. Radiation oncology. Baltimore, MD: Williams & Wilkins; 1998. p. 449–58.

    Google Scholar 

  21. Khan FM. The physics of radiation therapy. 4th ed. Lippincott Williams & Wilkins; 2009.

    Google Scholar 

  22. https://dotdecimal.com/products/electrons/apertures/.

  23. Gunderson L, Tepper J. Clinical radiation oncology. 4th ed. Elsevier; 2016.

    Google Scholar 

  24. Morrison WH, Gaden AS, Ang KK. Radiation therapy for non-melanomatous skin carcinoma. Clin Plast Surg. 1997;24:719–29.

    Article  Google Scholar 

  25. Guinot JL, et al. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol. 2018;126(3):377–85.

    Article  Google Scholar 

  26. Ouhib Z, Kasper M, Perez Calatayud J, Rodriguez S, Bhatnagar A, Pai S, Strasswimmer J. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. Brachytherapy. 2015;14(6):840–58. https://doi.org/10.1016/j.brachy.2015.06.005. Epub 2015 Aug 28.

    Article  Google Scholar 

  27. Villalba SR, Perez-Calatayud MJ, Bautista JA, Carmona V, Celada F, Tormo A, García-Martinez T, Richart J, Ortega MS, Silla M, Ballester F, Perez-Calatayud J. Novel simple templates for reproducible positioning of skin applicators in brachytherapy. J Contemp Brachytherapy. 2016;8(4):344–8.

    Article  Google Scholar 

  28. Likhacheva AO, Devlin PM, Shirvani SM, Barker CA, Beron P, Bhatnagar A, Doggett SW, Hochman L, Hsu C, Kasper M, Keisch M, Mutyala S, Prestidge B, Villalba SR, Shukla V, Sundararaman S, Kamrava M. Skin surface brachytherapy: a survey of contemporary practice patterns. Brachytherapy. 2017;16(1):223–9.

    Article  Google Scholar 

  29. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8:743.

    Article  Google Scholar 

  30. Fecher LA, Sharfman WH. Advanced basal cell carcinoma, the hedgehog pathway, and treatment options—role of smoothened inhibitors. Biol Targets Ther. 2015;9:129–40.

    Article  Google Scholar 

  31. Lear JT, Migden MR, Lewis KD, Chang ALS, Guminski A, Gutzmer R, Dirix L, Combemale P, Stratigos A, Plummer R, Castro H, Yi T, Mone M, Zhou J, Trefzer U, Kaatz M, Loquai C, Kudchadkar R, Sellami D, Dummer R. Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study. J Eur Acad Dermatol Venereol. 2018;32(3):372. Epub 2017 Nov 6.

    Article  Google Scholar 

  32. Basset-Séguin N, Hauschild A, Kunstfeld R, Grob J, Dréno B, Mortier L, Ascierto PA, Licitra L, Dutriaux C, Thomas L, Meyer N, Guillot B, Dummer R, Arenberger P, Fife K, Raimundo A, Dika E, Dimier N, Fittipaldo A, Xynos I, Hansson J. Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial. Eur J Cancer. 2017;86:334. Epub 2017 Nov 5.

    Article  Google Scholar 

  33. Xie P, Lefrançois P. Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;79(6):1089. Epub 2018 Jul 10.

    Article  Google Scholar 

  34. Kim J, Tang JY, Gong R, Kim J, Lee JJ, Clemons KV, Chong CR, Chang KS, Fereshteh M, Gardner D, Reya T, Liu JO, Epstein EH, Stevens DA, Beachy PA. Itraconazole, a commonly used antifungal that inhibits hedgehog pathway activity and cancer growth. Cancer Cell. 2010;17(4):388.

    Article  Google Scholar 

  35. Carneiro BA, Watkin WG, Mehta UK, Brockstein BE. Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Investig. 2006;24(4):396.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Penn Presbyterian Medical Center, Philadelphia, PA, USA

    Manuj Agarwal

  2. Prostate Cancer Institute of Arizona, Casa Grande, AZ, USA

    Ajay Bhatnagar

Authors
  1. Manuj Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ajay Bhatnagar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Washington, Seattle, WA, USA

    Edward Kim

  2. Department of Radiation Oncology, University of Washington, Seattle, WA, USA

    Upendra Parvathaneni

  3. Department of Radiation Oncology, The Ohio State University James Cancer Center, Columbus, OH, USA

    Meng Xu Welliver

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Agarwal, M., Bhatnagar, A. (2022). Basal Cell Carcinoma. In: Kim, E., Parvathaneni, U., Welliver, M.X. (eds) Radiation Therapy for Sarcomas and Skin Cancers. Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-031-06706-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-06706-8_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-06705-1

  • Online ISBN: 978-3-031-06706-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation